Evolving progress in the management of malignant plasma cell disorders
Cancer Treat Res Commun
.
2022:32:100612.
doi: 10.1016/j.ctarc.2022.100612.
Epub 2022 Jul 19.
Authors
Ezgi Atilgan
1
,
Wilson I Gonsalves
2
Affiliations
1
Division of Hematology, Mayo Clinic, Rochester, MN, United States.
2
Division of Hematology, Mayo Clinic, Rochester, MN, United States. Electronic address: gonsalves.wilson@mayo.edu.
PMID:
35872008
PMCID:
PMC9617662
DOI:
10.1016/j.ctarc.2022.100612
No abstract available
Publication types
Editorial
MeSH terms
Humans
Plasma Cells*
Grants and funding
R01 CA254961/CA/NCI NIH HHS/United States